steven_bradshaw

MKTXS appoints Dr Steven Bradshaw as director

July 30, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Global healthcare strategy firm MKTXS has appointed British medical research expert Dr Steven Bradshaw as its new European director. Market …

AstraZeneca secures respiratory drugs from Almirall

July 30, 2014
Research and Development, Sales and Marketing Almirall, AstraZeneca, Pfizer, Symbicort, lung drugs

AstraZeneca has paid $875 million to take control of Alimirall’s respiratory drug portfolio that includes treatments for bronchitis and emphysema. …

Amgen HQ

Amgen to wield axe on 2,900 jobs

July 30, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, Enbrel, Prolia, job cuts

Amgen has announced this morning that it will make swingeing cuts in the US over the next two years as …

Pfizer New York HQ

Pfizer revenue drops, but new cancer drugs shine

July 29, 2014
Research and Development, Sales and Marketing Cancer, Inlyta. axitinib, Lipitor, Lyrica, Pfizer, Q2, Sutent, viagra

Pfizer saw a 2% drop in sales for the second quarter but has pointed to the stellar growth of its …

atorvastatin

Copycat Lipitor helps toward £1.3bn NHS savings

July 29, 2014
Research and Development, Sales and Marketing ABPI, Lipitor, NHS, Teva, prescribing PPRS, vba

In 2013 generic usage increased to more than three-quarters of all NHS prescriptions according to new data released by the …

Roche

Roche’s blood cancer drug gains EU approval

July 29, 2014
Research and Development, Sales and Marketing CLL, Cancer, Gilead, Janssen, Roche

The European Commission has approved Roche’s new leukaemia drug Gazyvaro (obinutuzumab) as competition for the blood cancer market heats up. …

renee_mellas_23

Healthcare marketer Renée Mellas re-joins Area 23 as MD

July 29, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FCS Health

Healthcare and pharma marketing professional Renée Mellas has returned to Area  23, an FCB Health company, as executive vice president …

US doctor infected with Ebola as disease spreads

July 28, 2014
Medical Communications, Sales and Marketing Ebola, WHO

An American doctor working with Ebola patients in Liberia has been infected with the virus as health officials struggle to …

google_plaque

Google hopes DNA search will yield health results

July 27, 2014
Medical Communications, Research and Development, Sales and Marketing DNA, calico, google, smart lens

Google is to collect samples of human tissue from thousands of people as part of an experiment that could help …

european_flag

Europe warned over cancer research risk

July 27, 2014
Medical Communications, Research and Development, Sales and Marketing ESMO, EU, Macmillan, data

A leading European doctors’ group is warning that new data protection rules could make cancer research ‘impossible’ whilst also adding …

EMA HQ

EMA approvals for rival blood cancer drugs

July 27, 2014
Research and Development, Sales and Marketing CLL, Gilead, Janssen, chronic lymphocytic leukaemia, imbruvica, zydelig

Gilead and Janssen are set to face off in Europe after the CHMP recommended both of their rival blood cancer …

sovaldi_ariad_sofosbuvir_bottle_1

NHS England’s Sovaldi fund: opening the floodgates?

July 26, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDG, NICE, Professor David Haslam, hep C, sovaldi

Whilst seemingly more and more barriers are being erected to slow down the adoption of new medicines, there is a …

malaria_vaccine_trial_0

GSK seeks regulatory review of first malaria vaccine

July 26, 2014
Manufacturing and Production, Research and Development, Sales and Marketing China, GSK, malaria, rts, s

GSK has submitted a regulatory application to the European Medicines Agency for its malaria vaccine candidate RTS,S and hopes it …

More action needed on antibiotic resistance

July 25, 2014
Medical Communications, Research and Development, Sales and Marketing AMR, Antibiotics, AstraZeneca, GSK, HIV, MRC, WHO, walsh

Pharma and governments need to put their heads together urgently in order to tackle the threat of antimicrobial resistance (AMR), …

vicky_gregg

New director for Quest Diagnostics

July 25, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing quest diagnostics, vicky gregg

Diagnostic information services firm Quest Diagnostics has confirmed that Vicky Gregg is to serve as a director on its board. Gregg …

Lilly image

NICE extends recommendation for Efient

July 24, 2014
Sales and Marketing ACS, Efient, NICE, Plavix, longs ton, prasugrel

In updated guidance NICE has extended its recommendation of Efient (prasugrel) in combination with aspirin for preventing blood clots in …

Gilead image

FDA approves Gilead’s blood cancer drug

July 24, 2014
Research and Development, Sales and Marketing Cancer, FDA, Gilead, blood, follicular lymphoma and small lymphocytic lymphoma, lymphocytic leukaemia, sovaldi, zydelig

The Food and Drug Administration has approved Gilead Sciences new treatment Zydelig (idelalisib) to treat three types of blood cancer.  …

web_dr_dinesh_bhugra

New president for Mental Health Foundation

July 24, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dr Dinesh Bhugra, Mental Health Foundation

Dr Dinesh Bhugra who has served as chair of the Mental Health Foundation for three years has been appointed as …

Pradaxa image

BMJ investigation raises new concerns over Pradaxa

July 24, 2014
Medical Communications, Research and Development, Sales and Marketing BMJ, Boehringer, Channel 4, Pradaxa, blood, warfarin

An investigation by The BMJ has raised fresh concerns about Boehringer’s top-selling blood thinner Pradaxa (dabigatran) and the regulatory decisions …

gsk image

Another major drop in sales for GSK

July 23, 2014
Sales and Marketing China, GSK, Q2, Witty, bribery, sales, scandal, sex

GlaxoSmithKline posted a 4% slide in revenue for the second quarter today as its recovery from a slew of patent …

The Gateway to Local Adoption Series

Latest content